American Society of Hematology (ASH)

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

American Society of Hematology (ASH)
Dec 10, 2024, 16:55 | Societies
Highlights from Day 3 of ASH 2024
The 66th ASH Annual Meeting and Exposition held from December 7-10, 2024, in San Diego,…
Nov 6, 2024, 15:47 | Blog
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition will be held from…
Oct 7, 2024, 09:05 | Blog
Bria Carrithers: Never let labels determine what you achieve
Bria Carrithers, Postgraduate Year Four, American Society of Hematology (ASH), shared a post on X: "While applying…
Oct 2, 2024, 15:18 | Blog
Ahmet Emre Eşkazan: Happy to serve as Faculty for ASH 2025 Clinical Research Training Institute in MMENA Region
Ahmet Emre Eşkazan, Professor of Internal Medicine/Hematology, Istanbul University, shared a post on X: "I…
Jan 19, 2024, 18:00 | Blog
Prashant Mehta: My thoughts on developments in DLBCL management
Prashant Mehta, Senior Consultant and Assistant Professor in the Department of Medical Oncology/Hematology-oncology and Bone…
Jan 19, 2024, 17:40 | Opinion
Nishant Tiwari: Educational thread on hemophagocytic lymphohistiocytosis
Nishant Tiwari, Incoming Hematology-Oncology Fellow at OU Health Stephenson Cancer Centre, shared a thread on…
Dec 19, 2023, 00:08 | Blog
Feng Roger Luo: Primary results from a Phase 2 clinical trial evaluating ZYNLONTA® in Chinese patients with relapsed or refractory DLBCL
Feng Roger Luo, Chief Development Officer, Head of Clinical and Preclinical Development at Overland Pharmaceuticals,…
Dec 15, 2023, 06:34 | Blog
David Fajgenbaum: Can’t wait for our annual Castleman meeting tonight!
David Fajgenbaum, Founding Director of the Center for Cytokine Storm Treatment and Laboratory, shared on…
All: 8 Posts: 1 - 100
Special Coverage